Literature DB >> 1118889

Activated macrophages as cytotoxic effector cells.

J B Hibbs.   

Abstract

Mesh:

Substances:

Year:  1975        PMID: 1118889     DOI: 10.1097/00007890-197501000-00015

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  12 in total

1.  Comparison of various macrophage-inhibitory agents on vaginal and systemic herpes simplex virus type 2 infections.

Authors:  M B McGeorge; P S Morahan
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

2.  The differentiation of monocytes into macrophages, epithelioid cells, and multinucleated giant cells in subcutaneous granulomas. II. Peroxidatic activity.

Authors:  H J van der Rhee; C P van der Burgh-de Winter; W T Daems
Journal:  Cell Tissue Res       Date:  1979-04-12       Impact factor: 5.249

Review 3.  The role of macrophages in immunology.

Authors:  M A Elhelu
Journal:  J Natl Med Assoc       Date:  1983-03       Impact factor: 1.798

4.  Effects of trypan blue treatment on the immune responses of mice.

Authors:  M L Kripke; K C Norbury; E Gruys; J B Hibbs
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

5.  Enhancement of resistance to murine osteogenic sarcoma in vivo by an extract of Brucella abortus (Bru-Pel): association with activation of reticuloendothelial system macrophages.

Authors:  L A Glasgow; J L Crane; C J Schleupner; E R Kern; J S Youngner; D S Feingold
Journal:  Infect Immun       Date:  1979-01       Impact factor: 3.441

6.  In vivo and in vitro properties of malignant variants of RAW117 metastatic murine lymphoma/lymphosarcoma.

Authors:  C L Reading; P M Kraemer; K M Miner; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1983 Apr-Jun       Impact factor: 5.150

7.  Evans blue dye adjuvant enhances delayed hypersensitivity while blocking immunity to Mycobacterium tuberculosis in mice.

Authors:  D W Anderson; A J Crowle
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

8.  Ability of sera from mice treated with Ge-132, an organic germanium compound, to inhibit experimental murine ascites tumours.

Authors:  F Suzuki; R R Brutkiewicz; R B Pollard
Journal:  Br J Cancer       Date:  1985-11       Impact factor: 7.640

9.  Assessment of drug sensitivity of human leukaemic myeloblasts. I. Labelling human myeloblasts with 125IUdR for survival studies in mice.

Authors:  R P Falcão; S Sonis; I C MacLennan; D Chassoux; A J Davies; T R Munro
Journal:  Br J Cancer       Date:  1977-09       Impact factor: 7.640

10.  Possible role of macrophage-like suppressor cells in the anti-tumour activity of BCG.

Authors:  M Castés; N R Lynch; G Lespinats; S Orbach-Arbouys
Journal:  Br J Cancer       Date:  1981-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.